Pharming Group N.V. Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Pharming Group N.V. (PHAR) reported Effect Of Exchange Rate Changes On Cash And Cash Equivalents of $7.91 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Cash Flow
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents · last filed 2026-04-02
EUR
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month |
|---|---|
| 2020-12-31 | -12.63M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 1.35M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 2.88M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month |
|---|---|
| 2025-12-31 | $7.91M 20-F · filed 2026-04-02 |
| 2024-12-31 | -$2.21M 20-F · filed 2026-04-02 |
| 2023-12-31 | $2.13M 20-F · filed 2026-04-02 |
| 2022-12-31 | -$7.38M 20-F · filed 2025-04-03 |
| 2021-12-31 | -$1.82M 20-F · filed 2024-04-04 |
| 2020-12-31 | $2.13M 20-F · filed 2023-04-05 |
| 2019-12-31 | $60.00K 20-F · filed 2022-04-06 |